[HTML][HTML] Intersecting evidence: Bibliometric analysis and clinical trials illuminate immunotherapy in KRAS-mutation cancer: A review
H Liu, M Qiang, Y Zhang, H Wang, Y **ng, R Guo - Medicine, 2024 - journals.lww.com
KRAS mutations play a critical role in the development and progression of several cancers,
including non-small cell lung cancer and pancreatic cancer. Despite advancements in …
including non-small cell lung cancer and pancreatic cancer. Despite advancements in …
[HTML][HTML] eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer's vulnerability
S Casacuberta-Serra… - Translational Lung …, 2023 - ncbi.nlm.nih.gov
© Translational Lung Cancer Research. All rights reserved. Transl Lung Cancer Res 2023;
12 (12): 2570-2575| https://dx. doi. org/10.21037/tlcr-23-682 occurs in 40% of the cases …
12 (12): 2570-2575| https://dx. doi. org/10.21037/tlcr-23-682 occurs in 40% of the cases …
KRAS-Degrading Compounds: A Novel Approach to Treat Cancer by Targeting Both Wild-Type and Mutated KRAS Forms
RB Kargbo - ACS Medicinal Chemistry Letters, 2023 - ACS Publications
KRAS, a critical gene involved in cellular processes, can initiate tumor formation when
mutated. These mutations occur in about 20–30% of all human cancers, linking KRAS …
mutated. These mutations occur in about 20–30% of all human cancers, linking KRAS …
The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
G Gu, C Liu, Y Yang, Y Zhao, X Zhu… - Polish Journal of Pathology, 2024 - termedia.pl
Mutations in the KRAS gene in non-small cell lung cancer (NSCLC) are common drivers.
Gene expression and mutation data of NSCLC were collected from the TCGA dataset. DEGs …
Gene expression and mutation data of NSCLC were collected from the TCGA dataset. DEGs …
Sotorasib for non-small cell lung cancer—current options and perspectives
M Knetki-Wróblewska, B Wasąg - Oncology in Clinical …, 2024 - journals.viamedica.pl
ABSTRACT KRAS regulates several cellular processes, such as cell proliferation, cell cycle
regulation, metabolic changes, cell survival, and cell differentiation. Abnormalities in the …
regulation, metabolic changes, cell survival, and cell differentiation. Abnormalities in the …
[HTML][HTML] Current Understanding on Impact of Kirsten Rat Sarcoma Viral Oncogene Mutation on Colorectal Cancer: A Review
S Pakhira, P Samanta, R Ghosh… - Journal of Current …, 2024 - journals.lww.com
Globally, cancer is currently the second leading cause of mortality after cardiovascular
disease. In terms of death, colorectal cancer (CRC) ranks second among the most common …
disease. In terms of death, colorectal cancer (CRC) ranks second among the most common …
Sotorasib w leczeniu niedrobnokomórkowego raka płuca—aktualne możliwości i perspektywy
M Knetki-Wróblewska, B Wasąg - Onkologia w Praktyce …, 2024 - journals.viamedica.pl
Gen KRAS bierze udział w regulacji wielu procesów komórkowych, takich jak proliferacja,
różnicowanie i przeżycie komórek, regulacja cyklu komórkowego oraz zmiany metaboliczne …
różnicowanie i przeżycie komórek, regulacja cyklu komórkowego oraz zmiany metaboliczne …